tiprankstipranks
Oncoinvent ASA (DE:7BG)
FRANKFURT:7BG
Germany Market
7BG
Oncoinvent ASA
RESEARCH TOOLSreports

Oncoinvent ASA (7BG) Ratios

2 Followers

Oncoinvent ASA Ratios

DE:7BG's free cash flow for Q2 2026 was kr-5.40. For the 2026 fiscal year, DE:7BG's free cash flow was decreased by kr and operating cash flow was kr-8.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.43 3.23 4.79 3.71 2.14
Quick Ratio
 2.43 3.23 4.79 3.71 2.11
Cash Ratio
 2.24 3.06 4.34 3.33 1.93
Solvency Ratio
 -3.42 -2.45 -4.19 -4.06 -3.85
Operating Cash Flow Ratio
 -2.57 -2.19 -4.75 -4.80 -3.70
Short-Term Operating Cash Flow Coverage
 -60.18 -44.10 -346.70 -538.52 0.00
Net Current Asset Value
kr 68.06Mkr 128.68Mkr 121.45Mkr 127.05Mkr 88.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.03 0.02 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.02 0.02 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 <0.01 0.00 <0.01
Financial Leverage Ratio
 1.59 1.40 1.27 1.37 1.88
Debt Service Coverage Ratio
 -73.64 -45.02 -26.08 -15.28 -25.83
Interest Coverage Ratio
 0.00 -6.16K -32.18 -16.00 -26.54
Debt to Market Cap
 <0.01 0.05 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.45 2.88 0.16 0.87 1.53
Net Debt to EBITDA
 0.70 1.33 1.04 0.82 0.50
Profitability Margins
Gross Profit Margin
-418.23%-279.40%100.00%100.00%100.00%
EBIT Margin
-812.33%-615.20%-15870.52%-53622.32%-77583.80%
EBITDA Margin
-768.56%-566.37%-15816.75%-53559.32%-77356.81%
Operating Profit Margin
-812.33%-615.20%-17834.20%-54186.16%-78569.41%
Pretax Profit Margin
-877.36%-673.13%-16424.76%-53785.59%-77666.32%
Net Profit Margin
-877.36%-673.13%-16424.76%-53785.59%-77666.32%
Continuous Operations Profit Margin
-877.36%-673.13%-16424.76%-53785.59%-77666.32%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
108.01%109.42%92.10%99.26%98.85%
Return on Assets (ROA)
-133.47%-75.66%-89.40%-109.22%-181.23%
Return on Equity (ROE)
-150.82%-105.98%-113.51%-149.36%-341.39%
Return on Capital Employed (ROCE)
-196.53%-96.41%-122.44%-150.47%-344.29%
Return on Invested Capital (ROIC)
-191.69%-94.56%-121.57%-149.49%-340.28%
Return on Tangible Assets
-133.47%-75.66%-89.40%-109.22%-181.23%
Earnings Yield
-30.95%-254.85%-0.48%-0.44%-0.46%
Efficiency Ratios
Receivables Turnover
 2.20 2.96 1.25 0.50 0.57
Payables Turnover
 11.08 5.80 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 1.86 1.48 0.68 0.82 9.05
Asset Turnover
 0.15 0.11 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 0.20 0.18 <0.01 <0.01 <0.01
Cash Conversion Cycle
 133.34 60.45 292.26 725.88 638.05
Days of Sales Outstanding
 166.28 123.38 292.26 725.88 638.05
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 32.94 62.93 0.00 0.00 0.00
Operating Cycle
 166.28 123.38 292.26 725.88 638.05
Cash Flow Ratios
Operating Cash Flow Per Share
 -27.36 -102.32 -4.34 -15.73 -37.31
Free Cash Flow Per Share
 -27.40 -102.41 -4.34 -15.73 -37.31
CapEx Per Share
 0.03 0.10 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -790.54 -1.06K 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -790.54 -1.06K 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -60.18 -35.72 -187.34 -538.52 -1.05K
Operating Cash Flow to Sales Ratio
 -6.28 -5.50 -180.71 -635.88 -740.95
Free Cash Flow Yield
-22.18%-208.58%-0.53%-0.52%-0.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.48 -0.39 -207.09 -226.65 -219.15
Price-to-Sales (P/S) Ratio
 28.35 2.64 34.03K 121.90K 170.20K
Price-to-Book (P/B) Ratio
 6.86 0.42 235.18 338.52 748.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.51 -0.48 -188.31 -191.71 -229.71
Price-to-Operating Cash Flow Ratio
 -4.51 -0.48 -188.31 -191.71 -229.71
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 2.95 3.43 70.76
Price-to-Fair Value
 6.86 0.42 235.18 338.52 748.15
Enterprise Value Multiple
 -2.99 0.87 -214.10 -226.78 -219.53
Enterprise Value
 448.35M -113.21M 28.72B 43.00B 66.06B
EV to EBITDA
 -2.99 0.87 -214.10 -226.78 -219.53
EV to Sales
 22.98 -4.91 33.86K 121.46K 169.82K
EV to Free Cash Flow
 -3.65 0.89 -187.40 -191.02 -229.19
EV to Operating Cash Flow
 -3.66 0.89 -187.40 -191.02 -229.19
Tangible Book Value Per Share
 18.01 118.07 3.48 8.91 11.45
Shareholders’ Equity Per Share
 18.01 118.07 3.48 8.91 11.45
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.01
Revenue Per Share
 4.36 18.59 0.02 0.02 0.05
Net Income Per Share
 -38.22 -125.13 -3.95 -13.30 -39.11
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.08 1.09 1.03 1.00 1.00
Research & Development to Revenue
 3.16 2.73 103.41 304.48 520.32
SG&A to Revenue
 0.78 0.63 45.40 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 6.73 8.86 8.91
Income Quality
 0.72 0.82 1.10 1.18 0.95
Currency in NOK